Fifteen studies have investigated leptin levels in MS patients, with nine reporting significantly higher serum leptin levels compared to healthy controls [55,71,88,89,90,91,92,93,94,95,96,97,98,99,100]. Here, LEP is linked to myeloid sarcoma.